{"uid":"cap_zrMKo1u3LJ-BRgIh9ooCl","slug":"southpow-media-anix-insider-buys-sec-form-4-1c5f80ff","name":"southpow.media ANIX Insider Buys (SEC Form 4)","description":"ANIX insider BUYS from SEC Form 4 (open-market purchases by officers, directors, 10% owners), as filed. $0.01 USDC on Base. No account, no API key.","url":"https://southpow.media/v1/insider-buys/ANIX?utm_source=zero.xyz","method":"GET","headers":{},"bodySchema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET"],"type":"string"},"queryParams":{"type":"object","required":[],"properties":{"limit":{"type":"string","description":"Rows, 1-100 (default 20)"}},"additionalProperties":false}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}},"responseSchema":{"type":"json","example":{"as_of":"2026-11-03T00:00:00Z","count":1,"source":"SEC EDGAR Form 4 (open-market purchases)","insider_buys":[{"title":"Chief Executive Officer","ticker":"DLPN","buy_usd":4785,"insider":"O'Dowd William IV","is_ceo_or_cfo":true,"sec_accession":"0001400253-26-000010","filed_new_york":"2026-10-13 07:03:16","is_10pct_owner":true}]}},"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.01","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.01/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.01","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.01","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_GkaaleVIN5v5Bv9CAzBwL","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.01","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns open-market insider purchase transactions for ANIX (Anchiano Therapeutics) as filed in SEC Form 4, covering officers, directors, and 10%+ owners.","exampleAgentPrompt":"Pull the latest insider buy transactions for ANIX from SEC Form 4 — I want to see open-market purchases by officers and directors, give me the most recent 20.","exampleUseCases":[{"title":"Monitoring ANIX insider conviction signals","prompt":"Have any ANIX insiders been buying shares on the open market recently? Pull the SEC Form 4 purchases and show me who bought, how many shares, and at what price."},{"title":"Biotech due diligence before investing","prompt":"I'm researching ANIX before taking a position — can you check whether any officers or directors have been buying ANIX stock according to their SEC Form 4 filings?"},{"title":"Alerting on new ANIX insider purchases","prompt":"Check the latest ANIX insider buy filings from SEC Form 4 — give me up to 50 rows so I can see if there's been any significant accumulation by 10% owners or executives lately."}],"resultDescription":"A list of ANIX open-market insider purchase records sourced from SEC Form 4 filings, each including the insider's name, their role (officer, director, or 10%+ owner), transaction date, number of shares purchased, price paid, and filing metadata. Default returns up to 20 rows; can return up to 100 with the limit parameter.","failureModes":["No recent Form 4 filings available for ANIX returns empty result set","Payment of $0.01 USDC on Base not completed returns 402 Payment Required","Invalid limit parameter value (outside 1-100 range) returns validation error","SEC EDGAR data source temporarily unavailable returns upstream error","Network timeout if the data provider is slow to respond"],"whenToPreferThis":"Use this endpoint when you specifically need SEC Form 4 open-market insider buy data for ANIX (Anchiano Therapeutics). It is the right choice for equity research, conviction analysis, or monitoring executive sentiment for this ticker. It requires no account or API key and costs only $0.01 USDC via x402 on Base, making it ideal for lightweight, pay-per-call agent workflows. If you need insider data for other tickers or need to track insider sells, look for other endpoints.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-11-12T18:40:18.936Z","isFirstParty":false,"canonicalSlug":"southpow-media-anix-insider-buys-sec-form-4-1c5f80ff"}